Princeton Global Asset Management’s West Pharmaceutical WST Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$31.3K	Hold	125	–	–	0.01%	417
2025 Q4	$34.4K	Sell	125 -75	-38%	-$20.5K	0.01%	400
2025 Q3	$52.5K	Sell	200 -365	-65%	-$88.7K	0.01%	314
2025 Q2	$124K	Sell	565 -425	-43%	-$90.9K	0.02%	223
2025 Q1	$222K	Sell	990 -1,517	-61%	-$418K	0.04%	178
2024 Q4	$821K	Sell	2,507 -100	-4%	-$31.5K	0.15%	108
2024 Q3	$783K	Sell	2,607 -433	-14%	-$133K	0.15%	107
2024 Q2	$1M	Buy	3,040 +299	+11%	+$106K	0.22%	81
2024 Q1	$1.08M	Sell	2,741 -734	-21%	-$272K	0.26%	76
2023 Q4	$1.22M	Hold	3,475	–	–	0.31%	75
2023 Q3	$1.3M	Buy	3,475 +1,600	+85%	+$619K	0.37%	71
2023 Q2	$717K	Sell	1,875 -1,600	-46%	-$572K	0.21%	90
2023 Q1	$1.2M	Hold	3,475	–	–	0.35%	72
2022 Q4	$818K	Hold	3,475	–	–	0.26%	85
2022 Q3	$855K	Hold	3,475	–	–	0.3%	79
2022 Q2	$1.05M	Sell	3,475 -75	-2%	-$24.4K	0.34%	76
2022 Q1	$1.46M	Hold	3,550	–	–	0.4%	70
2021 Q4	$1.67M	Sell	3,550 -150	-4%	-$64.6K	0.47%	67
2021 Q3	$1.57M	Buy	3,700 +200	+6%	+$84.3K	0.48%	64
2021 Q2	$1.26M	Hold	3,500	–	–	0.38%	74
2021 Q1	$986K	Buy	3,500 +225	+7%	+$64.4K	0.32%	85
2020 Q4	$928K	Hold	3,275	–	–	0.32%	83
2020 Q3	$900K	Sell	3,275 -770	-19%	-$204K	0.36%	79
2020 Q2	$918K	Hold	4,045	–	–	0.29%	103
2020 Q1	$616K	Buy	4,045 +270	+7%	+$41.6K	0.27%	105
2019 Q4	$567	Buy	3,775 +250	+7%	+$36.4K	0.23%	104
2019 Q3	$493K	Hold	3,525	–	–	0.28%	98
2019 Q2	$441K	Hold	3,525	–	–	0.26%	103
2019 Q1	$388K	Hold	3,525	–	–	0.27%	96
2018 Q4	$346K	Buy	+3,525	New	+$382K	0.31%	87